US 9375475
Combination immunotherapy for the treatment of cancer
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 9375475 (Combination immunotherapy for the treatment of cancer) held by The Board of Regents of the University of Texas System expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K38/1709, A61K39/3955